GlassScriptPhysician profile
David S Goldstein
NPI 1740243906
$12,239.64
in general payments reported to CMS, 2019-2025
58 companies · $2,492 in 2025
The $2,492 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,048 · 2020: $332 · 2021: $837 · 2022: $1,311 · 2023: $3,910 · 2024: $2,310 · 2025: $2,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,186 · Travel and Lodging: $1,491 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,185.70 |
| Travel and Lodging | $1,491.00 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sn Holdings, LLC | $2,198.00 | 2023 | |
| Sumitomo Pharma America, INC. | $1,591.08 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $1,142.89 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $685.34 | 2019-2025 | Myrbetriq, Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $527.09 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $447.68 | 2019-2025 | Adstiladrin |
| Teleflex LLC | $438.76 | 2022-2025 | Urolift, Barrigel |
| Pfizer INC. | $373.99 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $335.64 | 2023-2025 | Pylarify |
| Urovant Sciences INC | $295.70 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $282.26 | 2019-2024 | Aveed, Xiaflex, Edex |
| Abbvie INC. | $280.62 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $237.64 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $236.79 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $199.94 | 2022-2025 | Keytruda, Lynparza, Welireg |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $199.83 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $196.93 | 2023-2025 | |
| Antares Pharma, INC. | $190.22 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Myovant Sciences INC. | $185.11 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $178.08 | 2022-2025 | Lynparza, Imfinzi |
| Endo USA, INC. | $149.44 | 2024-2025 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $125.72 | 2019-2022 | |
| Boston Scientific Corporation | $119.63 | 2020-2025 | Ams 700 |
| Blue Earth Diagnostics | $115.89 | 2021-2025 | Posluma |
| Sun Pharmaceutical Industries INC. | $115.09 | 2019-2024 | |
| Telix Pharmaceuticals | $114.09 | 2023 | Illuccix |
| Accord Healthcare, INC. | $110.59 | 2024-2025 | |
| Tolmar, INC. | $107.32 | 2023 | |
| Medtronic, INC. | $95.00 | 2023 | Interstim |
| Innovation Technologies INC | $86.16 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $86.06 | 2022-2024 | Opdivo |
| Novo Nordisk INC | $69.86 | 2024-2025 | Rivfloza |
| Immunitybio, INC. | $63.64 | 2025 | |
| Ethicon US, LLC | $58.95 | 2023-2025 | Echelon; Endopath, Stratafix |
| Janssen Scientific Affairs, LLC | $57.69 | 2019-2020 | |
| Davol INC. | $45.45 | 2025 | Arista |
| Tempus Ai, INC | $43.06 | 2024-2025 | Xt Cdx |
| Intuitive Surgical, INC. | $40.00 | 2021 | |
| Calyxo, INC. | $35.19 | 2025 | Cvac Aspiration System |
| Exelixis INC. | $34.61 | 2025 | Cabometyx |
| Verity Pharmaceuticals INC. | $33.33 | 2022-2025 | Trelstar |
| Valencia Technologies Corporation | $31.77 | 2025 | Ecoin Device Kit |
| Clovis Oncology, INC. | $27.12 | 2020 | |
| Myriad Genetic Laboratories, INC. | $25.66 | 2021-2022 | |
| Halozyme INC | $24.05 | 2023 | |
| Olympus America INC. | $20.40 | 2023 | Itind System |
| C. R. Bard, INC. & Subsidiaries | $19.47 | 2023 | Bard Urinary Drainage Bag |
| Vertex Pharmaceuticals Incorporated | $19.23 | 2025 | |
| Rochester Medical Corporation | $18.93 | 2021 | |
| Amgen INC. | $18.71 | 2022 | |
| Bioprotect Medical, INC. | $18.67 | 2025 | Bioprotect Balloon Implant System |
| Travere Therapeutics, INC. | $17.35 | 2019 | |
| Civco Medical Instruments | $16.07 | 2025 | |
| Acacia Pharma INC | $14.94 | 2021 | |
| Metuchen Pharmaceuticals | $14.10 | 2019 | |
| Foundation Medicine, INC. | $12.61 | 2022 | |
| Clarus Therapeutics INC. | $10.20 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.